Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 136th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Zen Rating
Momentum
Price
Volume
Vol 1d %
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
RSI
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D
MACD
MACD Signal
MACD Histogram
Beta
PBYI
PUMA BIOTECHNOLOGY INC
$9.78221,000-10.16%9.649.488.948.227.4159.1482.6978.4359.1854.500.220.210.010.97
PGEN
PRECIGEN INC
$8.054,134,00018.42%7.747.336.855.774.9365.5976.8873.1869.9261.490.310.270.041.79
ONC
BEONE MEDICINES LTD
$365.27372,0005.98%360.42356.84350.96321.20319.4456.9187.5383.0679.8575.823.563.070.490.98
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$39.29784,000-10.30%41.2841.5539.3236.3434.6441.9019.8628.979.4514.950.280.70-0.420.81
ICCC
IMMUCELL CORP
$9.942,900-35.56%9.949.9010.3210.128.4047.6765.0067.7065.7968.56-0.07-0.100.030.22
FENC
FENNEC PHARMACEUTICALS INC
$10.80118,000-43.81%10.7411.2211.1310.368.8945.6333.5225.5957.4835.96-0.20-0.15-0.050.71
CORT
CORCEPT THERAPEUTICS INC
$114.74963,000-16.62%114.61113.72111.7593.7669.5151.8558.9066.3856.6865.201.081.16-0.081.01
HALO
HALOZYME THERAPEUTICS INC
$111.562,574,00015.06%112.32110.28101.1386.4877.6357.8764.2070.9321.9938.333.243.62-0.380.76
VCYT
VERACYTE INC
$46.081,570,000-7.48%43.2842.9545.7348.0642.4755.6368.2074.1671.7680.640.11-0.720.821.89
REGN
REGENERON PHARMACEUTICALS INC
$750.51800,000-30.43%783.96797.36779.86712.36736.1137.2717.1526.2212.5226.20-4.672.06-6.730.59
ARQT
ARCUTIS BIOTHERAPEUTICS INC
$26.752,568,000-16.24%26.5425.1925.8324.9725.2655.9375.1471.0677.9175.420.480.180.291.21
PTCT
PTC THERAPEUTICS INC
$64.96899,000-53.03%65.0466.7770.4073.4472.3342.3542.4427.0665.4236.07-2.00-2.020.010.98
JAZZ
JAZZ PHARMACEUTICALS PLC
$232.35777,000-1.40%238.99241.40248.40241.64210.9236.7231.3331.3230.9429.98-3.30-2.61-0.700.69
PTGX
PROTAGONIST THERAPEUTICS INC
$140.97508,000-45.08%142.09144.18144.76129.02110.5444.7344.6735.2454.0736.94-1.29-0.68-0.610.93
RPRX
ROYALTY PHARMA PLC
$58.222,843,00052.60%58.3559.6459.4857.1750.7942.8821.1615.8452.3233.93-0.52-0.34-0.180.45
AUPH
AURINIA PHARMACEUTICALS INC
$16.42735,00017.41%16.6516.4015.9615.9815.5551.2045.8248.2710.6416.060.130.16-0.031.11
VCEL
VERICEL CORP
$40.61527,000-18.04%39.8739.7242.4640.9438.2350.3477.7565.8698.3089.17-0.60-0.860.271.43
ZVRA
ZEVRA THERAPEUTICS INC
$11.341,341,00080.73%11.4811.8311.4511.8510.5343.8918.0412.2526.9113.14-0.15-0.06-0.090.89
EXEL
EXELIXIS INC
$58.652,236,00074.82%57.8957.7555.6754.0848.8257.9582.1773.3866.4148.840.760.76-0.000.60
BCRX
BIOCRYST PHARMACEUTICALS INC
$8.275,006,00014.95%8.588.839.309.248.6736.2234.3732.8965.7561.72-0.29-0.28-0.011.07
BMRN
BIOMARIN PHARMACEUTICAL INC
$59.871,807,000-23.37%62.4364.0164.0059.9658.5933.518.025.953.271.09-1.16-0.47-0.690.70
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
$75.73286,000-61.04%76.8777.3176.2766.4055.7146.9124.7020.2115.269.45-0.110.32-0.440.80
OMER
OMEROS CORP
$19.25841,000-18.03%19.2818.9316.4113.6112.8656.0665.1272.3241.5952.290.830.91-0.081.56
ORMP
ORAMED PHARMACEUTICALS INC
$4.69171,00055.45%4.724.774.604.373.9048.1344.8644.1747.0347.470.010.03-0.021.16
XERS
XERIS BIOPHARMA HOLDINGS INC
$9.9819,315,000332.78%8.828.438.417.757.1674.5384.4086.38100.0098.850.310.100.211.23
INCY
INCYTE CORP
$123.201,712,00019.22%125.03124.90123.55114.26106.5447.4045.7147.8833.8037.600.210.53-0.320.53
FTRE
FORTREA HOLDINGS INC
$19.741,171,000-27.94%19.9918.8718.7417.4015.1255.9975.9275.9671.4573.510.490.400.101.69
RLYB
RALLYBIO CORP
$17.2216,7004.38%16.9716.9016.6716.0911.6958.0464.9845.1554.4330.180.080.09-0.011.12
CYPH
CYPHERPUNK TECHNOLOGIES INC
$3.2313,317,000-50.23%3.462.851.701.281.0758.6070.1882.1422.6942.990.580.570.011.81
PLX
PROTALIX BIOTHERAPEUTICS INC
$2.69899,0008.05%2.722.692.522.332.3254.7039.1150.160.0613.690.060.07-0.010.67
ANAB
ANAPTYSBIO INC
$50.37678,00064.16%52.8154.1855.2657.4456.4133.2215.6517.8912.2115.10-1.52-1.07-0.440.89
APMD
APNIMED INC
$23.90669,000135.56%24.6725.88N/AN/AN/A44.2721.1214.1219.867.83N/AN/AN/A0.95
ARGX
ARGENX SE
$970.66311,00017.36%973.32992.59953.46905.13850.2548.0143.7133.5249.0334.41-2.034.55-6.570.61
ACAD
ACADIA PHARMACEUTICALS INC
$20.222,513,000-28.67%24.4126.1527.2525.1024.5016.314.854.870.000.00-1.77-0.92-0.860.98
MGTX
MEIRAGTX HOLDINGS PLC
$11.13875,000-5.91%12.0412.7312.9611.9410.0729.7614.219.7810.825.32-0.59-0.34-0.251.27
ASND
ASCENDIS PHARMA A
$228.07742,000-0.80%233.62248.29250.23246.40235.3737.6815.3714.5023.8318.81-7.60-5.00-2.600.73
IOVA
IOVANCE BIOTHERAPEUTICS INC
$14.4577,402,000532.73%10.849.767.725.894.5586.4592.8391.7189.6081.701.220.950.271.48
HOWL
WEREWOLF THERAPEUTICS INC
$0.91970,00038.37%0.960.960.700.560.6554.1724.3039.670.1710.760.060.09-0.031.53
OABI
OMNIAB INC
$4.741,280,00089.63%4.644.503.703.002.3760.7573.0073.8654.8859.150.250.28-0.020.77
INSM
INSMED INC
$115.631,668,000-4.36%119.94122.81119.59112.66134.3641.0210.7116.660.267.26-1.080.05-1.130.98
RIGL
RIGEL PHARMACEUTICALS INC
$48.89182,0000.55%47.5347.4143.9138.9536.4561.4288.4884.0587.5678.291.161.120.041.27
GMAB
GENMAB A
$35.573,828,00036.96%34.9434.1532.3029.4729.5867.3292.2385.8695.1887.270.840.800.040.71
PRLD
PRELUDE THERAPEUTICS INC
$3.96458,000-7.66%4.354.694.994.693.8533.8710.168.147.414.61-0.35-0.25-0.101.55
VRTX
VERTEX PHARMACEUTICALS INC
$526.73655,000-20.61%518.30525.28516.07488.52472.7253.5085.1566.4698.1080.18-0.12-0.10-0.010.57
SLN
SILENCE THERAPEUTICS PLC
$10.80885,00024.47%11.7912.7912.7210.318.1429.654.065.250.550.37-0.52-0.24-0.280.76
LEGN
LEGEND BIOTECH CORP
$18.821,974,00015.10%18.3419.2120.1024.6422.4544.8152.3445.5590.7985.25-0.63-0.770.140.75
VIR
VIR BIOTECHNOLOGY INC
$10.651,523,00011.17%10.8110.9210.039.688.9550.5825.2830.655.067.020.140.23-0.091.37
ADMA
ADMA BIOLOGICS INC
$9.963,458,000-3.08%9.509.429.328.8911.9058.9082.6279.3484.3380.320.110.040.081.18
ANL
ADLAI NORTYE GROUP LTD
$15.6563,000-0.79%15.6915.2814.1312.6510.1355.7741.6147.215.867.680.500.58-0.070.89
SEPN
SEPTERNA INC
$39.13551,00063.02%38.8838.3838.8135.2930.7051.2453.6447.9646.8840.99-0.01-0.050.041.30
ARMP
ARMATA PHARMACEUTICALS INC
$3.5992,0006.98%3.924.664.795.887.3433.385.685.089.756.94-0.40-0.28-0.120.41
ARVN
ARVINAS INC
$7.50496,000-3.13%7.988.458.668.5110.2129.618.9410.490.000.00-0.35-0.23-0.121.40
MDGL
MADRIGAL PHARMACEUTICALS INC
$509.44214,000-35.93%520.51529.31525.75520.04511.6240.9525.1325.6010.338.66-4.20-1.53-2.680.77
FHTX
FOGHORN THERAPEUTICS INC
$3.52376,00011.57%3.894.325.254.855.0722.056.684.595.383.14-0.55-0.48-0.071.59
NRXS
NEURAXIS INC
$7.76103,00060.94%7.446.646.526.876.2866.4482.3081.8675.5578.270.370.230.141.09
SRZN
SURROZEN INC
$31.98558,00036.10%22.5621.5222.2323.5324.4468.7465.6862.3481.3178.071.64-0.051.690.73
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$7.651,745,000-10.14%7.367.207.046.174.7958.0789.5489.1196.8796.280.140.090.051.10
ALNY
ALNYLAM PHARMACEUTICALS INC
$254.07754,000-34.32%248.19251.43243.68268.67305.4054.3671.6056.0588.3071.981.690.780.920.86
URGN
UROGEN PHARMA LTD
$40.45638,000-45.28%42.2242.8443.9438.2729.6537.0817.1019.881.802.10-0.83-0.52-0.320.94
FBIO
FORTRESS BIOTECH INC
$2.20257,000-2.28%2.362.492.782.822.9927.295.442.988.122.71-0.15-0.13-0.021.13
TVTX
TRAVERE THERAPEUTICS INC
$59.991,547,00025.26%61.5663.7362.1956.4344.6641.6919.3418.8315.1911.25-0.85-0.17-0.681.17
TARS
TARSUS PHARMACEUTICALS INC
$76.69363,000-72.29%76.8779.4171.3566.5868.6251.5820.9314.1625.4416.350.931.84-0.910.87
KRYS
KRYSTAL BIOTECH INC
$335.06226,000-24.41%340.15346.64342.89336.33300.1543.7933.1437.2240.8750.85-1.99-1.00-0.991.28
HYPD
HYPERION DEFI INC
$3.99360,000-51.61%3.853.633.163.213.3960.5381.0285.5363.1575.220.240.210.021.38
NVO
NOVO NORDISK A S
$38.319,402,000-17.74%40.0042.4445.3445.7545.8429.669.088.4220.3316.79-2.10-1.72-0.380.67
AVXL
ANAVEX LIFE SCIENCES CORP
$2.361,756,000236.40%2.382.562.842.773.3835.7516.5614.0943.5832.94-0.16-0.15-0.011.75
KYMR
KYMERA THERAPEUTICS INC
$110.51447,000-38.26%115.80116.10114.57104.0492.7040.3112.5022.740.188.76-0.730.18-0.911.64
IMCR
IMMUNOCORE HOLDINGS PLC
$30.85344,00028.84%31.5533.1934.2732.2432.2732.1711.078.699.037.09-1.12-0.87-0.260.79
NAGE
NIAGEN BIOSCIENCE INC
$2.95279,000-32.12%3.013.053.143.354.3739.5623.7527.7636.8945.19-0.05-0.05-0.001.52
ARDX
ARDELYX INC
$3.394,370,00031.71%3.453.564.064.935.6831.8315.3617.4755.9560.13-0.18-0.200.031.18
YARW
YARROW BIOSCIENCE INC
$24.19101,000-6.48%27.0527.8134.0433.8231.5732.878.5915.9630.6539.71-2.60-2.45-0.151.03
INDP
INDAPTUS THERAPEUTICS INC
$2.85589,0000.86%3.552.811.992.272.2751.4062.2276.965.1424.370.500.52-0.011.12
MGNX
MACROGENICS INC
$3.77616,000-67.80%3.984.074.044.133.2342.0735.0727.1438.1222.20-0.07-0.03-0.031.49
XNCR
XENCOR INC
$25.001,621,0005.81%24.5825.0523.8818.6015.7652.2352.8935.9455.3632.480.100.26-0.151.18
RYTM
RHYTHM PHARMACEUTICALS INC
$95.71811,000-9.59%98.23100.45106.05101.8199.2034.0122.7925.4040.8448.31-2.74-2.63-0.111.16
MRNA
MODERNA INC
$203.4613,278,000-0.61%178.98161.81115.7086.5065.9776.4293.4693.6997.7498.2522.2719.402.871.40
RGNX
REGENXBIO INC
$7.452,096,00058.07%7.738.289.449.319.9735.6317.4912.9337.0723.51-0.63-0.60-0.031.52
IVA
INVENTIVA SA
$3.293,832,0009.99%3.553.994.384.395.0427.6519.0515.1547.6026.93-0.32-0.26-0.060.36
ELOX
ELOXX PHARMACEUTICALS INC
$15.426,100-62.80%16.3416.1416.4212.456.4845.4322.4726.395.588.63-0.25-0.02-0.23-107.26
LKFT
LAKEFRONT BIOTHERAPEUTICS NV
$29.52199,000-3.86%29.4628.6428.2828.4530.1854.7651.0455.9665.2074.230.440.270.160.60
ACIU
AC IMMUNE SA
$2.60139,000-26.46%2.662.712.572.552.8246.9031.5430.5018.4718.35-0.000.02-0.021.12
RANI
RANI THERAPEUTICS HOLDINGS INC
$0.80406,000-35.04%0.790.820.820.831.0248.4632.3018.8344.3030.53-0.02-0.01-0.011.38
STTK
SHATTUCK LABS INC
$6.54957,000-2.05%6.216.356.946.455.7950.2164.6852.0384.3877.89-0.18-0.240.051.43
IFRX
INFLARX NV
$145.000-100.00%16.309.224.863.492.2999.6636.7115.7633.3311.1111.372.279.10-0.33
SRPT
SAREPTA THERAPEUTICS INC
$18.641,368,000-39.68%19.4920.5318.7518.1119.1743.5318.7313.3311.187.00-0.180.20-0.381.09
CCCC
C4 THERAPEUTICS INC
$3.131,554,000-44.08%3.223.413.663.763.1034.9326.6720.4840.8620.09-0.20-0.17-0.032.03
AXSM
AXSOME THERAPEUTICS INC
$186.141,578,000123.20%200.72205.30212.86224.89199.2732.4511.7713.594.766.77-5.58-3.79-1.790.88
ZYME
ZYMEWORKS INC
$27.20684,000-50.29%26.9827.5226.0225.2725.1051.1547.3636.2358.0542.910.060.18-0.120.93
ASMB
ASSEMBLY BIOSCIENCES INC
$23.48230,00094.92%24.5128.6629.0427.8028.5527.904.223.640.060.06-2.15-1.51-0.640.99
PYPD
POLYPID LTD
$5.2966,000-13.16%5.255.264.874.864.6254.1056.0854.2441.8641.450.080.09-0.010.76
ALGS
ALIGOS THERAPEUTICS INC
$5.6211,500-85.53%5.445.555.755.726.8048.3549.3747.5786.2183.23-0.15-0.180.031.46
XFOR
X4 PHARMACEUTICALS INC
$2.901,706,000103.58%3.263.503.863.953.9224.4712.489.353.152.52-0.27-0.21-0.061.34
UTHR
UNITED THERAPEUTICS CORP
$481.47415,000-33.92%488.52493.83509.86531.15524.4839.7429.0323.6747.4531.36-8.57-7.56-1.010.40
INVA
INNOVIVA INC
$21.11556,000-34.97%20.9421.0021.0521.7121.7651.7465.9447.7282.3662.58-0.06-0.080.020.37
SCTX
SCRIBE THERAPEUTICS INC
$23.03671,000118.57%26.4628.25N/AN/AN/A38.9211.968.729.653.92-0.930.40-1.33-0.62
EDIT
EDITAS MEDICINE INC
$2.591,568,000-28.86%2.702.802.852.902.6442.2713.7815.5312.5417.20-0.09-0.07-0.022.11
CMMB
CHEMOMAB THERAPEUTICS LTD
$1.61438,00025.14%2.282.472.121.941.8326.876.016.860.000.00-0.090.04-0.141.08
KURA
KURA ONCOLOGY INC
$10.811,890,00014.82%11.2111.7411.1710.649.8040.9113.249.308.742.91-0.23-0.05-0.181.10
CRSP
CRISPR THERAPEUTICS AG
$56.001,575,00023.92%55.9255.1153.9153.4053.3152.2136.6737.9443.3444.390.190.26-0.071.58
RARE
ULTRAGENYX PHARMACEUTICAL INC
$15.325,855,00018.52%14.6015.6521.9624.5824.4037.3859.3957.3386.0283.63-2.30-2.720.421.08

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: B, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 24 points higher than the biotech industry average of 24.

PBYI passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 93.66% over the past year, overperforming other biotech stocks by 167 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -38.65% from Puma Biotechnology's current stock price of $9.78.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Precigen (NASDAQ:PGEN)


Precigen (NASDAQ:PGEN) is the #2 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Precigen (NASDAQ:PGEN) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: F, Financials: C, and AI: B.

Precigen (NASDAQ:PGEN) has a Due Diligence Score of 29, which is 5 points higher than the biotech industry average of 24.

PGEN passed 10 out of 33 due diligence checks and has average fundamentals. Precigen has seen its stock return 121.76% over the past year, overperforming other biotech stocks by 195 percentage points.

Precigen has an average 1 year price target of $13.67, an upside of 69.78% from Precigen's current stock price of $8.05.

Precigen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Precigen, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)


Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 28, which is 4 points higher than the biotech industry average of 24.

ONC passed 9 out of 33 due diligence checks and has average fundamentals. Beone Medicines has seen its stock return 9.75% over the past year, overperforming other biotech stocks by 83 percentage points.

Beone Medicines has an average 1 year price target of $418.55, an upside of 14.59% from Beone Medicines's current stock price of $365.27.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Beone Medicines, 81.82% have issued a Strong Buy rating, 18.18% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Oramed Pharmaceuticals (NASDAQ:ORMP)


Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.33%, which is 3 percentage points higher than the biotech industry average of 2.12%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)


Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.84%, which is 3 percentage points higher than the biotech industry average of 2.12%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its high dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the biotech industry average of 2.12%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 48.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.59% in the last day, and down -3.09% over the last week. Stablecoin Development was the among the top gainers in the biotechnology industry, gaining 108.28% yesterday.

Stablecoin Development shares are trading lower. The company announced it is aware of unusual trading activity and that there has been no material development in its business and affairs.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 42.15% in the past year. It has overperformed other stocks in the biotech industry by 115 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)


Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 80.09% in the past year. It has overperformed other stocks in the biotech industry by 153 percentage points.

3. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 44.56% in the past year. It has overperformed other stocks in the biotech industry by 118 percentage points.

Are biotech stocks a good buy now?

64.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 63.92% over the next year.

3.04% of biotech stocks have a Zen Rating of A (Strong Buy), 3.69% of biotech stocks are rated B (Buy), 44.9% are rated C (Hold), 36.88% are rated D (Sell), and 11.5% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 9.98x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.